The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Open accessAbstract
Exosomes are attractive as nucleic-acid carriers because of their favourable pharmacokinetic and immunological properties and their ability to penetrate physiological barriers that are impermeable to synthetic drug-delivery vehicles. However, inserting exogenous nucleic acids, especially large messenger RNAs, into cell-secreted exosomes leads to low yields. Here we report a cellular-nanoporation method for the production of large quantities of exosomes containing therapeutic mRNAs and targeting peptides. We transfected various source cells with plasmid DNAs and stimulated the cells with a focal and transient electrical stimulus that promotes the release of exosomes carrying transcribed mRNAs and targeting peptides. Compared with bulk electroporation and other exosome-production strategies, cellular nanoporation produced up to 50-fold more exosomes and a more than 10 3-fold increase in exosomal mRNA transcripts, even from cells with low basal levels of exosome secretion. In orthotopic phosphatase and tensin homologue (PTEN)-deficient glioma mouse models, mRNA-containing exosomes restored tumour-suppressor function, enhanced inhibition of tumour growth and increased survival. Cellular nanoporation may enable the use of exosomes as a universal nucleic-acid carrier for applications requiring transcriptional manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Compared to exosomes produced endogenously without involving external stimuli, CNP-treated exosomes from cells of the same origin have an increased mRNA encapsulation efficiency of 3–4 folds.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A tumour suppressor gene, like phosphatase and tensin homologue (PTEN), is commonly mutated in wide ranges of GBM, which may be a great candidate for therapeutic intervention27,54.”
From Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system (2025) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“The CNP technology increases the exosome yield and the mRNA amount within the exosomes [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In addition, this strategy increased mRNA loading in exosomes by 100-fold compared to conventional electroporation methods.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“By modifying the exosome CD47 with these peptides, the targeting ability was improved.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Chemical modification of exosomes was carried out to target GL261 gliomas and U87 glioblastomas.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Moreover, when PTEN mRNA was additionally modified with the CDX peptide, the resulting exosomes exhibited a twofold increase in accumulation in mouse U87 gliomas, leading to prolonged survival.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Similarly, modification of PTEN mRNA with CREKA peptide resulted in a 1.5-fold increase in accumulation in mouse U87 gliomas and improved survival [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Yang et al. modified CD47-derived exosomes by incorporating a glioma targeting peptide at the N terminus. This modification allowed for selective uptake of tumor suppression gene, phosphatase and tensin homolog (PTEN) cargo by glioma cells. As a result, the proliferation of tumor cells was effectively inhibited [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In Yang et al. research, mouse embryonic fibroblast-derived exosomes were able to deliver PTEN (phosphatase and homologous tensin) mRNA to inhibit mouse glioma growth [49].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [49]
In the citing paper
“Naturally derived membrane lipids (for example, exosomes and cell membranes) can also be applied for mRNA delivery116,249,250.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [249]
In the citing paper
“However, large-scale production and purification of natural exosomes present significant challenges. Standardization of isolation techniques remains an area of ongoing research, with variations in yield and purity across different methods [36].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,763
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,329
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Self-citation
Cited by
Sorted by citations
Items 501–600 of 744
Guo, L., Lin, X., Wang, Q., Liu, Z., Liu, S., Lv, N., Liu, Z., Wang, Y., Sun, C., & Wang, Y. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03248-x · Cited by 10
Self-citationWang, Y., Zhang, Y., Zhou, L., Li, Y., Zu, X., Zhang, J., Yao, W., Yang, S., Wang, Y., Chen, D., et al. (2025) · Small · doi:10.1002/smll.202508210 · Cited by 9
Self-citationGao, L., Feng, Q., Cui, B., Mao, Y., Zhao, Z., Liu, Z., & Zhu, H. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01104 · Cited by 10
Chen, R., Yang, H., Dai, J., Zhang, M., Lu, G., Zhang, M., Yu, H., Zheng, M., & He, Q. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.02.007 · Cited by 9
Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
Sharma, S., Rana, R., Prakash, P., & Ganguly, N. K. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04715-1 · Cited by 10
Vitucci, E. C. M., Carberry, C. K., Payton, A., Herring, L. E., Mordant, A. L., McCullough, S. D., & Rager, J. E. (2023) · iScience · doi:10.1016/j.isci.2023.108162 · Cited by 9
Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors
Machado, C. M. L., Skubal, M., Haedicke, K., Pittella-Silva, F., Stater, E. P., Silva, T. L. A. D. O., Costa, E. T., Masotti, C., Otake, A. H., Andrade, L. N. D. S., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.038 · Cited by 9
Jin, Y., Sun, L., Chen, Y., & Lu, Y. P. (2024) · Cancer Medicine · doi:10.1002/cam4.6936 · Cited by 10
Self-citationYu, T., Wang, J., Zhou, Y., Ma, C., Bai, R., Huang, C., Wang, S., Liu, K., & Han, B. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402861 · Cited by 10
Huber, C., Elsaeed, O., Lahmer, P., & Moertl, S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01845-x · Cited by 9
Macrophage-centered therapy strategies: A promising weapon in cancer immunotherapy
Wang, S., Liu, J., Cui, Y., Sun, M., Wang, W., Chen, J., Gu, J., & Yang, Z. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101063 · Cited by 10
Self-citationClinical insights into extracellular vesicles for targeted myocardial drug delivery
Wang, H., Wei, G., Yin, J., Yang, M., Tong, L., & Wang, J. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2555488 · Cited by 8
Patil, J., Singh, A., Bhalerao, S., Ahmad, S. F., Rawal, R., Bhatia, D. D., & Solanki, R. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c01251 · Cited by 8
Advanced Materials and Delivery Systems for Enhancement of Chimeric Antigen Receptor Cells
Li, T., Luo, R., Su, L., Lv, F., Mei, L., & Yu, Y. (2023) · Small Methods · doi:10.1002/smtd.202300880 · Cited by 8
Effective exosomes in breast cancer: focusing on diagnosis and treatment of cancer progression
Abdullaev, B., Rasyid, S. A., Ali, E., Al‐Dhalimy, A. M. B., Mustafa, Y. F., Fenjan, M. N., Misra, N., Al‐Musawi, S. G., Alawadi, A. H., & Alsalamy, A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154995 · Cited by 8
Yang, Z., Rao, J., Liang, Z., Xu, X., Lin, F., Lin, Y., Wang, C., & Chen, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.989295 · Cited by 9
Self-citationSatheeshan, G., Kumar, A., Rutta, J., & Venkatesh, T. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01404-0 · Cited by 7
Unleashing the potential of mRNA : Overcoming delivery challenges with nanoparticles
Chen, Q., Huo, K.-G., Ji, S., Pang, S., Sun, T., Niu, Y., Jiang, Z., Zhang, P., Han, S., & Li, J. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10713 · Cited by 8
Johnston, J., Jeon, H., Choi, Y. Y., Kim, G., Shi, T. H., Khong, C., Chang, H., Myung, N. V., & Wang, Y. (2024) · Biomaterials Science · doi:10.1039/d4bm00504j · Cited by 8
Self-citationPre-formation loading of extracellular vesicles with exogenous molecules using photoporation
Ramon, J., Pinheiro, C., Vandendriessche, C., Lozano−Andrés, E., Keersmaecker, H. D., Punj, D., Fraire, J. C., Geeurickx, E., Wauben, M. H. M., Vader, P., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03640-3 · Cited by 9
Extracellular vesicle-based protein and RNA delivery
Li, T., Xing, H., Huang, Y., & Lu, M. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126300 · Cited by 8
Setia, A., Patil, D., Randhave, N. V., Vaishali, Verma, N., Rani, K., Kale, A., Wagh, B., Kumar, V., Malik, A. K., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150582 · Cited by 9
Ji, W., Zhang, D., Wang, X., Pang, Y., Huang, L., Li, J., Li, X., Zou, X., He, S., Yu, Y., et al. (2026) · Advanced Functional Materials · doi:10.1002/adfm.202523026 · Cited by 7
Self-citationMicrofluidics for separation, detection, and engineering of extracellular vesicles
Heikal, L., Hamdallah, S. I., El-Habashy, S. E., Ashour, A. A., El‐Moslemany, R. M., & El-Kamel, A. H. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115810 · Cited by 8
Liu, C. J. S., Wang, S.-B., Su, P.-Y., Hsieh, Y.-P., & Wang, H.-Y. A. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115851 · Cited by 7
Man, F., Xing, H., Wang, H., Wang, Y., & Lu, R. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1043130 · Cited by 7
Self-citationBhardwaj, J. S., Paliwal, S., Singhvi, G., & Taliyan, R. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123089 · Cited by 7
Wang, J., Rao, G., Ma, Y., Zhang, J., Shen, J., & Shi, C. (2020) · Dose-Response · doi:10.1177/1559325820917288 · Cited by 7
Self-citationMeneses, D. D., Figueroa‐Valdés, A. I., Georges, N., Tobar, H. E., & Alcayaga‐Miranda, F. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10349 · Cited by 7
Bioengineering extracellular vesicles as novel nanocarriers towards brain disorders
Wu, J., Ma, L., Sun, D., Zhang, X., Cui, J., Du, Y., Guo, Y., Wang, X., Di, L., & Wang, R. (2022) · Nano Research · doi:10.1007/s12274-022-4913-2 · Cited by 8
Self-citationProgress of extracellular vesicles-based system for tumor therapy
Wang, F., Yin, L., & Hu, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.066 · Cited by 7
Wang, C., Zhao, X., Yan, T., Zhang, S., Li, X., Chen, Y., Wu, W., Qiao, Z., Chen, Q., Wang, X., et al. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c00094 · Cited by 6
Self-citationQuiñones, E. D., Yu, J., Liu, R.-Z., Li, Y.-S., Lu, Y.-C., & Hsiao, Y. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c05442 · Cited by 6
Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy
Kwak, S., Lee, H., Yu, D., Jeon, T., Kim, S. M., & Ryu, H. (2025) · Biosensors · doi:10.3390/bios15080504 · Cited by 7
Extracellular Vesicles in Drug Delivery: From Quality Assurance to Therapeutic Application
Zhang, K., & Fang, J. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s579695 · Cited by 8
Adaptive Polymers: The pH-Responsive Revolution in Biomedical Materials
Musale, S., Jarande, S. S., Nikam, A., Pawar, R., Kodange, N. N., Kapare, H. S., Nison, M., Pai, V., Aher, A. A., Datta, D., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c01425 · Cited by 6
Holghoomi, R., Rahdar, A., Kadkhoda, J., Mohammadzadeh, V., Shirzad, M., Salehi, B., Ebrahimi, M.-S., & Pandey, S. (2026) · Nano LIFE · doi:10.1142/s179398442630013x · Cited by 6
Drug delivery systems for treatment of temporomandibular joint osteoarthritis
Huang, X., Pan, X., Xiong, X., Zhao, Z., & Cen, X. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1054703 · Cited by 6
Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma
He, W., Wang, N., Wang, Y.-P., Liu, M., Qing, Q., Su, Q., Zou, Y., & Liu, Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040482 · Cited by 6
Self-citationDelivery approaches of immunomodulatory nucleic acids for cancer therapy
Hu, X., Enbar, T., & Tang, L. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103182 · Cited by 6
Liu, X., Li, Z., Fu, J., Wang, R., He, J., Yao, J., Ye, Q., & He, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s528190 · Cited by 6
Kodidela, S., Godse, S., Kumar, A., Nguyen, X. H., Cernasev, A., Zhou, L., Singh, A. K., Bhat, H. K., & Kumar, S. (2022) · Biology · doi:10.3390/biology11020177 · Cited by 6
Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19
Bortot, B., Romani, A., Ricci, G., & Biffi, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.877422 · Cited by 6
Exosomes in sarcoma: Prospects for clinical applications
Ye, H., Tan, L., Tu, C., & Min, L. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103895 · Cited by 7
Unlocking Delivery Strategies for mRNA Therapeutics
Luo, Z., & Chen, Y. (2023) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892818666230607093231 · Cited by 6
Self-citationNucleic Acid Delivery Nanotechnologies for In Vivo Cell Programming
Balcorta, H. V., Guerrero, V., Bisht, D., & Poon, W. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00886 · Cited by 8
Biomimetic Nanostructure Platform for Cancer Diagnosis Based on Tumor Biomarkers
He, X., Ma, Y., Xie, H., Rao, G., Yang, Z., Zhang, J., & Feng, Z. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.687664 · Cited by 6
Self-citationZou, Z., Wen, S., Yu, Q., Li, Y., An, J., Xiong, Y., Wu, Q., Tong, L., Wu, C., Mei, X., et al. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c03712 · Cited by 5
Yang, J., & Liu, B. (2025) · Cancer Nanotechnology · doi:10.1186/s12645-025-00322-5 · Cited by 7
Chen, Q., Wang, W., He, X., Wang, C., Guo, H., & Ou, C. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218034 · Cited by 7
Unlocking the potential of extracellular vesicles: one stimulus away from clinical implementation
Silva, R. M., Azevedo, A. M., Bonifácio, V. D. B., Fernandez-Becerra, C., & Pinto, S. N. (2025) · Biomaterials Science · doi:10.1039/d5bm01091h · Cited by 7
Harnessing the power of exosomes in leukemia: from molecular messengers to clinical applications
Ansarian, M. A., Fatahichegeni, M., Wang, Y., Ren, J., & Wang, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-03814-3 · Cited by 5
Self-citationLiu, Z., Wei, S., Peng, M., Qin, H., Wang, H., Wang, S., Wang, Z., Zhang, M., & Liu, K. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01054 · Cited by 5
Liu, D., Hao, Z., He, G., & Huang, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s562593 · Cited by 5
Cheng, S., Ma, Y., Huang, F., Luo, R., Han, L., He, L., & Yuan, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s555771 · Cited by 7
Self-citationExtracellular vesicle-based delivery systems for nucleic acid therapeutics
Zhang, X., Liu, X., Zhou, Q., & Yao, K. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102870 · Cited by 6
Zeng, H., Wang, Q., Wang, F., Tian, Y., Xie, Y., Dai, D., Meng, Y., Zou, C., Wei, L., He, X., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04210-x · Cited by 5
Self-citationGenerating exosome subtypes: diverse membrane origins and mergers
Goberdhan, D. C. I., Harris, A. L., & WILSON, C. G. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.03.009 · Cited by 7
The Long Journey of Extracellular Vesicles towards Global Scientific Acclamation
Pirisinu, M. (2022) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.049 · Cited by 6
Rano, S., Bhaduri, A., & Singh, M. (2023) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2023.106876 · Cited by 8
Yang, L. H., Niu, Z., Ma, Z., Wu, X., Vong, C. T., Li, G., & Feng, Y. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03507-x · Cited by 5
Vesicles: New Advances in the Treatment of Neurodegenerative Diseases
Nuzzo, D., Girgenti, A., Palumbo, L., Naselli, F., Bavetta, M., Marfia, G., & Picone, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312672 · Cited by 5
Zhang, S., Zhao, X., Lv, Y., Niu, J., Wei, X., Luo, Z., Wang, X., & Chen, X. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb02351j · Cited by 5
Self-citationApplication of engineered extracellular vesicles to overcome drug resistance in cancer
NONAKA, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1070479 · Cited by 5
RNA technology and nanocarriers empowering in vivo chimeric antigen receptor therapy
Cai, J., Chen, S., Liu, Z., Li, H., Wang, P., Yang, F., Li, Y., Chen, K., Sun, M., & Qiu, M. (2024) · Immunology · doi:10.1111/imm.13861 · Cited by 5
Development and Advantages of Drug Delivery Systems
Zhang, Y., Liu, X., & Li, X. (2025) · Springer eBooks · doi:10.1007/978-981-19-8930-8_2 · Cited by 5
[Progress in extracellular vesicle imaging methods].
Wang, K., Wei, Y., Zhang, P., Wang, J., Hu, J., Wang, L., & Li, B. (2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.02.22 · Cited by 5
Zhou, Y., Hu, Y., Lü, X., Yang, H., Li, Q., Du, C., Chen, Y., Hong, K. H., & Sun, H. (2020) · Dose-Response · doi:10.1177/1559325820938526 · Cited by 5
Self-citationMesenchymal stem cell exosomes: a promising delivery system for glioma therapy
Ma, T., Su, G., Wu, Q., Shen, M., Feng, X., & Zhang, Z. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2023-0482 · Cited by 5
Cellular Toxicity Study of Silicon Nanowires
Song, Z., Wu, F., Zheng, Y., Xu, X., Tang, Q., & Bian, B. (2020) · Dose-Response · doi:10.1177/1559325820918761 · Cited by 5
Soft and fibrous multiplexed biosensors
Feiner, R., & Dvir, T. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0522-0 · Cited by 5
Hu, T., Duan, R., Gao, H., Bai, X., Huang, X. L., Yan, X., Li, A., Ma, Y., Chen, R., Hong, S., et al. (2024) · Cytotechnology · doi:10.1007/s10616-024-00634-1 · Cited by 4
Self-citationTherapeutic potential of extracellular vesicle-polyphenol nanoplatform in regenerative medicine
Ma, M., Wu, Q., Wang, T., Ma, Y., Le, F., Wang, Y., Jiang, L., Gu, Z., & Hao, Z. (2025) · Nano Materials Science · doi:10.1016/j.nanoms.2025.05.008 · Cited by 5
Self-citationLPAR4-targeted dual-loaded liposome for synergistic lung cancer therapy
Wang, S., Jiang, H., Liu, J., Chen, J., Hu, S., Cui, Y., Wang, X., Sun, S., Li, J., Teng, L., et al. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107176 · Cited by 4
Self-citationJiang, R., Wang, H., Zhong, F., Hu, Y., Liu, J., Chen, Y., Su, W., Cao, S., Deng, Q., & Zhou, Q. (2025) · Biomedical Materials · doi:10.1088/1748-605x/ade925 · Cited by 4
Self-citationCustomised extracellular vesicle therapeutics for neurological conditions
Johnston, E. L., Weber, J. F., Sango, X., Nisbet, I. T., & Haylock, D. N. (2025) · Health Nanotechnology · doi:10.1186/s44301-025-00007-3 · Cited by 4
Zhang, L., Parvin, R., Lin, S., Chen, P., Wang, G., Hu, D., Lin, K., Cheng, Y., Ye, F., Han, B., et al. (2025) · Advanced Science · doi:10.1002/advs.202509407 · Cited by 4
Li, Y., Zhang, M., Gu, J., He, Y., Zhou, M., & Lin, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108960 · Cited by 4
Recent advances in engineering approaches for delivery of mRNA-based therapeutics
Prinindya, K. N. N., Ashraf, G. M., Uddin, S., Mahdi, E., & Hasan, A. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214667 · Cited by 6
Nanotechnology-driven drug delivery systems for breast cancer: A review
Wang, T., Chen, Y., Zhang, X., Dou, Y., Chen, Y., Xie, M., Motta, A., Zheng, Z., Wang, X., Kuang, X., et al. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214725 · Cited by 4
Self-citationYoussef, J. R., Elgammal, E. M., Mahdy, D. M., Ghazi, N., & Bebawy, G. (2026) · Pharmaceutical Research · doi:10.1007/s11095-026-04095-3 · Cited by 6
Martins, A. M. V., Pilão, S., dos Santos, S. G., Neidlinger‐Wilke, C., Ignatius, A. A., Gonçalves, R. M., & Teixeira, G. Q. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.05.036 · Cited by 4
Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy
Tian, Y. W., Liu, Y., Tong, Y., Huntoon, K. M., Yang, L., Shi, J., Ma, Y., Dong, S., Jeong, S. D., Estania, A. P., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01689-5 · Cited by 5
Self-citationEffects of Bioactive Glasses (BGs) on Exosome Production and Secretion: A Critical Review
Gorgani, S., Hosseini, S. A., Wang, A. Z., Baino, F., & Kargozar, S. (2023) · Materials · doi:10.3390/ma16114194 · Cited by 6
Exosome-Based Drug Delivery Systems
Huang, R., Zhou, J., & Chen, S. (2025) · Physiology · doi:10.5772/intechopen.1009138 · Cited by 4
Ling, L., Liang, S., Cai, M., Ge, J., Tan, H., Wang, C.-B., & Xu, B. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101646 · Cited by 4
Asadujjaman, M., Nam, Y. R., Lee, D.-E., Choi, J. U., Kim, S. H., Jang, D.-J., & Jee, J. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00774-2 · Cited by 5
Design and Synthesis of Shikimoylated-Polypeptides for Nuclear Specific Internalization
Mondal, B., Mahadik, N. S., Banerjee, R., & Gupta, S. S. (2022) · ACS Macro Letters · doi:10.1021/acsmacrolett.1c00740 · Cited by 4
Research Progress of Extracellular Vesicles Targeted Therapy
Chen, Y., & Hou, S. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200255 · Cited by 4
Self-citationWu, C., Chen, J., Zhang, J., Hong, H., Jiang, J., Ji, C., Li, C., Xia, M., Xu, G., & Cui, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134330 · Cited by 4
RetractedGu, Z., Xue, W., Mao, G., Pei, Z., Li, J., Sun, M., Zhang, X., Zhang, S., Li, S., Cen, J., et al. (2025) · Small Science · doi:10.1002/smsc.202400606 · Cited by 3
Yang, J.-J., He, S., Huang, B., Wang, P.-X., Feng, X., Lin, X., & Liu, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1550208 · Cited by 3
Li, N., Zhang, W., Zhao, J., Huang, Y., Zhao, Z., Chen, T., Wang, D., Zhang, D., Deng, M., Zheng, C., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02905 · Cited by 4
Self-citationFan, Y., Pan, W., Xiu, Q., Qiao, Y., Zhang, P., Liao, T., Feng, J., Nie, C., Chu, S., Li, N., et al. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.118032 · Cited by 3
Self-citationScalable bioelectronic production of extracellular vesicles for cardiac tissue regeneration
Meng, L., Zhang, J., Li, P., Li, W., Shi, J., Cheng, Z., Ostroff, E., Yang, C., Yue, J., Promiński, A., et al. (2025) · Device · doi:10.1016/j.device.2025.100968 · Cited by 3
Self-citationYan, Y., You, Y., Ma, S., Yi, H. J., Chen, G., Ni, J., Chen, C., Ke, W., Li, L., Bai, R., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70186 · Cited by 3
Self-citationZhang, H., Sun, M., Chen, J., Wang, S., Liu, J., Yang, H., Liu, L., Hu, S., Yang, F., Teng, L., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114493 · Cited by 3
Self-citationAdvances in immune cell-based therapeutic agents for the treatment of inflammation-related diseases
Yang, Y., Liu, J., Liu, J., Wei, S., Kong, X., Mu, W., Liu, Y., & Zhang, N. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.013 · Cited by 6
Liu, J., Luo, L., Feng, K., & Xie, X. (2026) · BIO Integration · doi:10.15212/bioi-2025-0177 · Cited by 3
Rahmani, P., Fakhri, M., Aghajani, A., Nikeghbal, S., Motlagh, F. R., Rafiei, S., Hassanzadeh, B., Salajegheh, P., Shadi, M., & Akhavan‐Sigari, R. (2026) · Discover Nano · doi:10.1186/s11671-026-04533-6 · Cited by 3
Metadata
- Authors
- Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., Malkoc, V., Chiang, C., Deng, W., Chen, Y., Fu, Y., Kwak, K. J., Fan, Y., Kang, C., Yin, C., Rhee, J., Bertani, P., Otero, J., Lu, W., Yun, K., Lee, A. S., Jiang, W., Teng, L., Kim, B. Y. S., & Lee, L. J.
- Affiliations
- The Ohio State University (US)
- Jilin University (CN)
- The University of Texas Southwestern Medical Center (US)
- Jinan University (CN)
- Mayo Clinic (US)
- Peking University (CN)
- Institute for Stem Cell Biology and Regenerative Medicine (US)
- Houston Methodist Research Institute (US)
- Shenzhen Bay Laboratory (CN)
- Corresponding author
- Teng, Lesheng
- Kim, Betty Y. S.
- Lee, L. James
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2019-12-16
- Volume
- 4
- Issue
- 1
- Pages
- 69-83
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC7080209
- OpenAlex
- W2995128645
- Cited by
- 744
- References
- 49
- Citations by year
- 2026: 81 · 2025: 125 · 2024: 135 · 2023: 128 · 2022: 117 · 2021: 101 · 2020: 56
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-15)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA241070)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS104315)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- exosomes, mRNA delivery, electroporation, exosome production, targeting peptides, tumor suppression, nucleic acid carriers, exosome secretion, brain tumors
- MeSH terms
- Animals, Brain Neoplasms, Cells, Cultured, Disease Models, Animal, Glioma, Humans, Mice, Inbred C57BL, RNA, Messenger, Signal Transduction, Drug Delivery Systems, Electroporation, MicroRNAs, Nanotechnology, Exosomes, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
